- Entry
- $1.29
- Now
- $1.29 +0.0%
- Target
- —
- Score
- —
On October 5, BioNexus Gene Lab (BGLC) signed an agreement with Ruanyun Edai Technology (RYET) for an exclusive Malaysian healthcare licence to CogniAI, RYET’s document-intelligence platform. BGLC says its first target is Malaysia’s public healthcare digitalisation programme, but it has no government contract. The $3.5 million figure in coverage describes something narrower than a cash price. **What the filing says** (8-K filed 2026-10-07, accession 0001477932-26-006075, Items 1.01 and 3.02, full agreement attached as Ex. 10.1) * **Licence payment:** 410,000 new …
— ORIGINAL POST ·
BGLC’s “$3.5M” CogniAI licence from RYET: 410,000 new shares worth ~$521k at today’s price, 19% dilution, and it hasn’t closed
· r/SecurityAnalysis
· Oct 9, 2026